Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Avid Bioservices Inc (CDMO)

Avid Bioservices Inc (CDMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avid Bioservices Inc 14191 Myford Road Tustin CA 92780 USA

www.avidbio.com Employees: 371 P: 714-508-6100 F: 714-838-5817

Description:

Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. It also offer process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. Avid Bioservices Inc., formerly known as Peregrine Pharmaceuticals Inc., is based in TUSTIN, United States.

Key Statistics

Overview:

Market Capitalization, $K 700,469
Enterprise Value, $K 662,359
Shares Outstanding, K 63,795
Annual Sales, $ 139,910 K
Annual Net Income, $ -140,750 K
Last Quarter Sales, $ 40,170 K
Last Quarter Net Income, $ -5,530 K
EBIT, $ -18,970 K
EBITDA, $ -6,360 K
60-Month Beta 1.40
% of Insider Shareholders 3.05%
% of Institutional Shareholders 97.16%
Float, K 61,849
% Float 96.95%
Short Volume Ratio 0.90

Growth:

1-Year Return 108.52%
3-Year Return -67.42%
5-Year Return 109.94%
5-Year Revenue Growth 161.03%
5-Year Earnings Growth -105.88%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.03 on 09/09/24
Next Earnings Date 12/05/24
Earnings Per Share ttm -0.37
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -133.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-7 on 07/10/17

CDMO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -16.53%
Return-on-Assets % -5.60%
Profit Margin % -100.60%
Debt/Equity 0.00
Price/Sales 4.81
Price/Cash Flow 68.34
Price/Book 11.47
Book Value/Share 0.92
Interest Coverage -5.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar